PubMed:26215578 / 2086-2436
Annnotations
c_corpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T311 | 58-65 | CHEBI:34922 | denotes | pathway |
T312 | 76-80 | PR:000007171 | denotes | EREG |
T313 | 76-80 | PR:O14944 | denotes | EREG |
T314 | 76-80 | PR:Q61521 | denotes | EREG |
T315 | 76-80 | PR:Q9Z0L5 | denotes | EREG |
T316 | 85-88 | CHEBI:340824 | denotes | MMP |
T319 | 85-88 | CHEBI:59761 | denotes | MMP |
T321 | 85-90 | Q11133 | denotes | MMP-1 |
T322 | 85-90 | P13943 | denotes | MMP-1 |
T323 | 85-90 | PR:P03956 | denotes | MMP-1 |
T324 | 85-90 | P21692 | denotes | MMP-1 |
T325 | 85-90 | PR:Q8GWW6 | denotes | MMP-1 |
T326 | 85-90 | P81563 | denotes | MMP-1 |
T327 | 85-90 | PR:000010469 | denotes | MMP-1 |
T328 | 85-90 | Q9XSZ5 | denotes | MMP-1 |
T329 | 85-90 | P28053 | denotes | MMP-1 |
T330 | 85-90 | PR:Q12372 | denotes | MMP-1 |
T331 | 85-90 | P03956 | denotes | MMP-1 |
T320 | 85-90 | GO:0004232 | denotes | MMP-1 |
T332 | 115-124 | GO:0009058 | denotes | formation |
T333 | 140-146 | UBERON:0000310 | denotes | breast |
T334 | 140-153 | D001943 | denotes | breast cancer |
T335 | 140-153 | D001943 | denotes | breast cancer |
T336 | 242-252 | D015415 | denotes | biomarkers |
T337 | 242-252 | D015415 | denotes | biomarkers |
UseCases_ArguminSci_Discourse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T14 | 0-154 | DRI_Background | denotes | Together, these studies lead to identification of a novel pathway involving EREG and MMP-1 that contributes to the formation of early stage breast cancer. |
T15 | 155-350 | DRI_Background | denotes | Understanding these complex pathways could ultimately lead to the development of novel biomarkers of neoplastic progression and/or new therapeutic strategies for patients with early stage cancer. |
PubMed_Structured_Abstracts
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 0-350 | CONCLUSIONS | denotes | Together, these studies lead to identification of a novel pathway involving EREG and MMP-1 that contributes to the formation of early stage breast cancer. Understanding these complex pathways could ultimately lead to the development of novel biomarkers of neoplastic progression and/or new therapeutic strategies for patients with early stage cancer. |
DisGeNET5_gene_disease
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
26215578-13#76#80#gene2069 | 76-80 | gene2069 | denotes | EREG |
26215578-13#85#90#gene4312 | 85-90 | gene4312 | denotes | MMP-1 |
26215578-13#128#153#diseaseC2986665 | 128-153 | diseaseC2986665 | denotes | early stage breast cancer |
76#80#gene2069128#153#diseaseC2986665 | 26215578-13#76#80#gene2069 | 26215578-13#128#153#diseaseC2986665 | associated_with | EREG,early stage breast cancer |
85#90#gene4312128#153#diseaseC2986665 | 26215578-13#85#90#gene4312 | 26215578-13#128#153#diseaseC2986665 | associated_with | MMP-1,early stage breast cancer |